HKEX Stock Code: 01093English|繁體|简体

Highlight - 2024 3Q

Revenue
RMB22,686M, -4.9%
Underlying profit attributable to shareholders
RMB3,999M, -15.2%
Reported profit attributable to shareholders
RMB3,778M, -15.9%
Basic earnings per share (reported)
RMB33.90 cents, -14.6%
Basic earnings per share (underlying profit)
RMB32.03 cents, -15.4%

Key Products

Finished drugs
Bulk drugs
© Copyright 2024 CSPC Pharmaceutical Group Limited. All Rights Reserved.